MIM
ICPT
MetLife Investment Management’s Intercept Pharmaceuticals, Inc. ICPT Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-21,600
| Closed | -$400K | – | 2894 |
|
|
2023
Q3 | $400K | Buy |
21,600
+8,853
| +69% | +$164K | ﹤0.01% | 1770 |
|
|
2023
Q2 | $141K | Hold |
12,747
| – | – | ﹤0.01% | 2487 |
|
|
2023
Q1 | $171K | Hold |
12,747
| – | – | ﹤0.01% | 2310 |
|
|
2022
Q4 | $158K | Hold |
12,747
| – | – | ﹤0.01% | 2392 |
|
|
2022
Q3 | $178K | Sell |
12,747
-3,729
| -23% | -$52K | ﹤0.01% | 2370 |
|
|
2022
Q2 | $228K | Hold |
16,476
| – | – | ﹤0.01% | 2224 |
|
|
2022
Q1 | $268K | Buy |
16,476
+5,261
| +47% | +$85.6K | ﹤0.01% | 2165 |
|
|
2021
Q4 | $183K | Hold |
11,215
| – | – | ﹤0.01% | 2101 |
|
|
2021
Q3 | $167K | Hold |
11,215
| – | – | ﹤0.01% | 2201 |
|
|
2021
Q2 | $224K | Hold |
11,215
| – | – | ﹤0.01% | 2091 |
|
|
2021
Q1 | $259K | Hold |
11,215
| – | – | ﹤0.01% | 1899 |
|
|
2020
Q4 | $277K | Hold |
11,215
| – | – | ﹤0.01% | 1809 |
|
|
2020
Q3 | $465K | Hold |
11,215
| – | – | 0.01% | 1402 |
|
|
2020
Q2 | $537K | Hold |
11,215
| – | – | 0.01% | 1337 |
|
|
2020
Q1 | $706K | Hold |
11,215
| – | – | 0.01% | 1049 |
|
|
2019
Q4 | $1.39M | Hold |
11,215
| – | – | 0.01% | 949 |
|
|
2019
Q3 | $744K | Hold |
11,215
| – | – | 0.01% | 1204 |
|
|
2019
Q2 | $892K | Buy |
11,215
+1,537
| +16% | +$122K | 0.01% | 1163 |
|
|
2019
Q1 | $1.08M | Hold |
9,678
| – | – | 0.01% | 1047 |
|
|
2018
Q4 | $975K | Buy |
9,678
+453
| +5% | +$45.7K | 0.01% | 1025 |
|
|
2018
Q3 | $1.17M | Sell |
9,225
-928
| -9% | -$117K | 0.01% | 1061 |
|
|
2018
Q2 | $852K | Buy |
+10,153
| New | +$852K | 0.01% | 1096 |
|